EBON:NASDAQEbang International Holdings Inc. Analysis
Data as of 2026-06-18 - not real-time
$2.46
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Ebang International is trading well below its long‑term moving average, with the 20‑day SMA sitting beneath the 50‑day SMA, a classic bearish signal, yet the MACD has just turned bullish and the histogram is positive, suggesting a potential short‑term bounce. The RSI sits in the upper‑mid range, indicating momentum is still intact but not overbought, and volume is on an upward trend, adding confidence to the recent price recovery toward the mid‑range of its recent range.
The fundamentals paint a starkly different picture: revenue has collapsed dramatically year over year, margins are deeply negative, and cash flow remains in the red despite a modest cash pile. The balance sheet shows a high debt‑to‑equity ratio and a price‑to‑book that is a fraction of one, flagging a severe valuation disconnect. Combined with extreme 30‑day price swings, a beta well above market, and exposure to the volatile blockchain sector, the stock carries pronounced risk across multiple dimensions.
The fundamentals paint a starkly different picture: revenue has collapsed dramatically year over year, margins are deeply negative, and cash flow remains in the red despite a modest cash pile. The balance sheet shows a high debt‑to‑equity ratio and a price‑to‑book that is a fraction of one, flagging a severe valuation disconnect. Combined with extreme 30‑day price swings, a beta well above market, and exposure to the volatile blockchain sector, the stock carries pronounced risk across multiple dimensions.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish moving‑average alignment
- Negative earnings and cash flow
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential technical bounce from bullish MACD
- Continued cash burn and weak profitability
- Uncertainty around blockchain regulatory environment
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Structural revenue decline and negative margins
- Elevated debt burden relative to equity
- Persistent sector and regulatory headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth-21.30%
Profit Margin-215.60%
ROE-5.61%
ROA-5.37%
Debt/Equity1.93
P/B Ratio0.1
Op. Cash Flow$-9045139
Free Cash Flow$-18468040
Industry P/E38.1
Technical Analysis
TrendBearish
RSI58.5
Support$1.80
Resistance$2.70
MA 20$2.13
MA 50$2.23
MA 200$3.17
MACDBullish
VolumeIncreasing
Fear & Greed Index91.23
Valuation
GradeFair
TypeValue
Risk Assessment
Beta1.49
Volatility108.13%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.